P2X7R was demonstrated to activate NLRP3 inflammasome to enhance collagen-induced arthritis in mice, and sinomenine exhibited therapeutic roles in collagen-induced arthritis by targeting the P2X7R-NLRP3 pathway 57. This evidence concerns the gene NLRP3 and Arthritis.